Prevalence and risk factors for elevated anxiety symptoms and anxiety disorders in chronic kidney disease: A systematic review and meta-analysis
- PMID: 33516963
- DOI: 10.1016/j.genhosppsych.2020.12.003
Prevalence and risk factors for elevated anxiety symptoms and anxiety disorders in chronic kidney disease: A systematic review and meta-analysis
Abstract
Background: Anxiety is associated with poor health outcomes among chronic kidney disease (CKD) patients. This review summarizes the prevalence and risk factors associated with elevated anxiety symptoms and disorders among CKD patients.
Methods: Articles evaluating the prevalence and risk factors associated with elevated anxiety symptoms and disorders among CKD patients, as diagnosed via DSM 4th or 5th edition criteria, clinical interviews or validated questionnaires, were searched in Medline®, Embase®, PsychINFO® and CINAHL®. Using random-effects meta-analyses, the prevalence of elevated anxiety symptoms and disorders were estimated. A narrative review on the risk factors associated with elevated anxiety symptoms and disorders was presented.
Results: From 4941 articles, 61 studies were included. The pooled prevalence of anxiety disorders (9 studies, n = 1071) among CKD patients across studies was 19% while that of elevated anxiety symptoms (52 studies, n = 10,739) was 43%. Across continents, prevalence of elevated anxiety symptoms was highest in Europe and Asia. Between pre-dialysis and dialysis patients, the prevalence of elevated anxiety symptoms was not statistically different at 31% and 42% respectively. Common risk factors associated with elevated anxiety symptoms included concomitant depression, lower parathyroid hormone levels, increased comorbidities, increased duration of hospitalization, reduced perceived quality of life, and decreased vitality levels.
Conclusion: Given the high prevalence of anxiety disorders and elevated anxiety symptoms, more studies are required to assess the role and outcomes of anxiety screening among CKD patients. This could facilitate early identification of at-risk patients and potentially improve their clinical outcomes.
Keywords: Anxiety; Anxiety disorders; Chronic renal insufficiency; Epidemiology; Psychiatry; Renal dialysis; Risk factors.
Copyright © 2020 Elsevier Inc. All rights reserved.
Similar articles
-
Psychosocial factors in people with chronic kidney disease prior to renal replacement therapy.Nephrology (Carlton). 2013 Sep;18(9):585-91. doi: 10.1111/nep.12138. Nephrology (Carlton). 2013. PMID: 23876102
-
Anxiety, depression, resilience and quality of life in children and adolescents with pre-dialysis chronic kidney disease.Pediatr Nephrol. 2015 Dec;30(12):2153-62. doi: 10.1007/s00467-015-3159-6. Epub 2015 Jul 27. Pediatr Nephrol. 2015. PMID: 26210984
-
Association of depressive and anxiety symptoms with adverse events in Dutch chronic kidney disease patients: a prospective cohort study.BMC Nephrol. 2015 Sep 21;16:155. doi: 10.1186/s12882-015-0149-7. BMC Nephrol. 2015. PMID: 26390864 Free PMC article.
-
Prevalence of sleep disorders in children with chronic kidney disease: a meta-analysis.Pediatr Nephrol. 2022 Nov;37(11):2571-2582. doi: 10.1007/s00467-022-05536-y. Epub 2022 Apr 20. Pediatr Nephrol. 2022. PMID: 35445975 Review.
-
Symptom burden and health-related quality of life in chronic kidney disease: A global systematic review and meta-analysis.PLoS Med. 2022 Apr 6;19(4):e1003954. doi: 10.1371/journal.pmed.1003954. eCollection 2022 Apr. PLoS Med. 2022. PMID: 35385471 Free PMC article.
Cited by
-
Emotional and cognitive changes in chronic kidney disease.Korean J Intern Med. 2022 May;37(3):489-501. doi: 10.3904/kjim.2021.492. Epub 2022 Mar 8. Korean J Intern Med. 2022. PMID: 35249316 Free PMC article. Review.
-
Association of cardiovascular-kidney-metabolic health and social connection with the risk of depression and anxiety.Psychol Med. 2024 Nov 18;54(15):1-9. doi: 10.1017/S0033291724002381. Online ahead of print. Psychol Med. 2024. PMID: 39552398 Free PMC article.
-
Prevalence and outcomes associated with hypocalcaemia and hypercalcaemia among pre-dialysis chronic kidney disease patients with mineral and bone disorder.Singapore Med J. 2024 Aug 1;65(8):421-429. doi: 10.4103/singaporemedj.SMJ-2021-391. Epub 2022 Nov 2. Singapore Med J. 2024. PMID: 36453429 Free PMC article.
-
eHealth Solutions for Symptom Assessment and Monitoring in Adults With Chronic Kidney Disease: A Systematic Review.J Clin Nurs. 2025 Sep;34(9):3560-3591. doi: 10.1111/jocn.17827. Epub 2025 May 14. J Clin Nurs. 2025. PMID: 40369651 Free PMC article. Review.
-
Effect of psychosocial interventions for depression in adults with chronic kidney disease: a systematic review and meta-analysis.BMC Nephrol. 2024 Jan 10;25(1):17. doi: 10.1186/s12882-023-03447-0. BMC Nephrol. 2024. PMID: 38200465 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical